Skip to main content

Table 3 Medications currently prescribed as acute or preventive migraine treatment for ≥5% of patients with episodic and chronic migraine: physician-reported data

From: Real-world treatment patterns and patient-reported outcomes in episodic and chronic migraine in Japan: analysis of data from the Adelphi migraine disease specific programme

Medication

Cohort

Total

(n = 977)

p-value

Episodic migraine (n = 923)

Chronic migraine (n = 54)

Acute treatment

 Eletriptan

91 (9.9)

2 (3.7)

93 (9.5)

0.134a

 Naratriptan

133 (14.4)

11 (20.4)

144 (14.7)

0.230a

 Sumatriptan

162 (17.6)

7 (13.0)

169 (17.3)

0.386a

 Rizatriptan

148 (16.0)

14 (25.9)

162 (16.6)

0.057a

 Zolmitriptan

113 (12.2)

6 (11.1)

119 (12.2)

0.805a

 Loxoprofen

275 (29.8)

18 (33.3)

293 (30.0)

0.581a

 Diclofenac

48 (5.2)

4 (7.4)

52 (5.3)

0.525b

Preventive treatment

 Lomerizine

131 (14.2)

13 (24.1)

144 (14.7)

0.046a

 Valproic acid

116 (12.6)

17 (31.5)

133 (13.6)

< 0.001a

 Amitriptyline

61 (6.6)

8 (14.8)

69 (7.1)

0.048b

  1. Data are n (%)
  2. aChi-squared test
  3. bFisher’s exact test